PharmaShots | Incisive News in 3 Shots

Subscribe Now

applied therapeutics

Applied Therapeutics Receives Complete Response Letter for Govorestat’s NDA for Treating Classic Galactosemia

Applied Therapeutics Receives Complete Response Letter for Govorestat’s NDA for Treating Classic Galactosemia

November 28, 2024

Applied Therapeutics Reports the US FDA’s Acceptance of NDA with Priority Review for Govorestat to Treat Classic Galactosemia

Applied Therapeutics Reports the US FDA’s Acceptance of NDA with Priority Review for Govorestat to Treat Classic Galactosemia

February 29, 2024

Applied Therapeutics Reports Results for Govorestat (AT-007) in P-III Trial for the Treatment of Sorbitol Dehydrogenase (SORD) Deficiency

Applied Therapeutics Reports Results for Govorestat (AT-007) in P-III Trial for the Treatment of Sorbitol Dehydrogenase (SORD) Def...

February 17, 2024

Applied Therapeutics Reports P-III trial (INSPIRE) Results of AT-007 for Sorbitol Dehydrogenase Deficiency

Applied Therapeutics Reports P-III trial (INSPIRE) Results of AT-007 for Sorbitol Dehydrogenase Deficiency

February 17, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us